136 related articles for article (PubMed ID: 22896677)
41. Ubiquitin enzymes, ubiquitin and proteasome activity in blood mononuclear cells of MCI, Alzheimer and Parkinson patients.
Ullrich C; Mlekusch R; Kuschnig A; Marksteiner J; Humpel C
Curr Alzheimer Res; 2010 Sep; 7(6):549-55. PubMed ID: 20455864
[TBL] [Abstract][Full Text] [Related]
42. Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones.
Elkharaz J; Ugun-Klusek A; Constantin-Teodosiu D; Lawler K; Mayer RJ; Billett E; Lowe J; Bedford L
Biochim Biophys Acta; 2013 Dec; 1832(12):1930-8. PubMed ID: 23851049
[TBL] [Abstract][Full Text] [Related]
43. Postnatal proteasome inhibition induces neurodegeneration and cognitive deficiencies in adult mice: a new model of neurodevelopment syndrome.
Romero-Granados R; Fontán-Lozano Á; Aguilar-Montilla FJ; Carrión ÁM
PLoS One; 2011; 6(12):e28927. PubMed ID: 22174927
[TBL] [Abstract][Full Text] [Related]
44. Expanding the role of proteasome homeostasis in Parkinson's disease: beyond protein breakdown.
Bi M; Du X; Jiao Q; Chen X; Jiang H
Cell Death Dis; 2021 Feb; 12(2):154. PubMed ID: 33542205
[TBL] [Abstract][Full Text] [Related]
45. Aggregation of mutant cysteine string protein-α via Fe-S cluster binding is mitigated by iron chelators.
Naseri NN; Ergel B; Kharel P; Na Y; Huang Q; Huang R; Dolzhanskaya N; Burré J; Velinov MT; Sharma M
Nat Struct Mol Biol; 2020 Feb; 27(2):192-201. PubMed ID: 32042150
[TBL] [Abstract][Full Text] [Related]
46. Cysteine string proteins.
Gundersen CB
Prog Neurobiol; 2020 May; 188():101758. PubMed ID: 32044380
[TBL] [Abstract][Full Text] [Related]
47. Quercetin targets cysteine string protein (CSPalpha) and impairs synaptic transmission.
Xu F; Proft J; Gibbs S; Winkfein B; Johnson JN; Syed N; Braun JE
PLoS One; 2010 Jun; 5(6):e11045. PubMed ID: 20548785
[TBL] [Abstract][Full Text] [Related]
48. Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration.
Lee CS; Lee C; Hu T; Nguyen JM; Zhang J; Martin MV; Vawter MP; Huang EJ; Chan JY
Proc Natl Acad Sci U S A; 2011 May; 108(20):8408-13. PubMed ID: 21536885
[TBL] [Abstract][Full Text] [Related]
49. Decoding transcriptomic signatures of cysteine string protein alpha-mediated synapse maintenance.
Wang N; Zhu B; Allnutt MA; Grijalva RM; Zhao H; Chandra SS
Proc Natl Acad Sci U S A; 2024 Jun; 121(24):e2320064121. PubMed ID: 38833477
[TBL] [Abstract][Full Text] [Related]
50. [Significance of increased and reduced proteasome activity in the pathomechanism of selected disorders].
Tylicka M; Matuszczak E; Karpińska M; Dębek W
Postepy Hig Med Dosw (Online); 2016 May; 70():448-58. PubMed ID: 27180963
[TBL] [Abstract][Full Text] [Related]
51. Turning-ON Proteasomes.
Krahn JH; Kaschani F; Kaiser M
Cell Chem Biol; 2017 Jun; 24(6):653-655. PubMed ID: 28644955
[TBL] [Abstract][Full Text] [Related]
52. Proteasomal degradation of tyrosine hydroxylase and neurodegeneration.
Nakashima A
J Neurochem; 2012 Jan; 120(2):199-201. PubMed ID: 22035286
[No Abstract] [Full Text] [Related]
53. Neurodegeneration, mitochondrial dysfunction, and oxidative stress.
Streck EL; Czapski GA; Gonçalves da Silva C
Oxid Med Cell Longev; 2013; 2013():826046. PubMed ID: 24191177
[No Abstract] [Full Text] [Related]
54. COVID-19 and Parkinson's disease: a casual association or a possible second hit in neurodegeneration?
Cavallieri F; Fioravanti V; Toschi G; Grisanti S; Napoli M; Moratti C; Pascarella R; Versari A; Fraternali A; Casali M; Paul JJ; Moro E; Bauer P; Zedde M; Valzania F
J Neurol; 2022 Jan; 269(1):59-61. PubMed ID: 34216264
[No Abstract] [Full Text] [Related]
55. Correlative Cellular Mass Spectrometry Imaging and Amperometry Show Dose Dependent Changes in Lipid Composition and Exocytosis.
Barut I; He X; Sener E; Sämfors S; Ewing AG; Fletcher JS
Angew Chem Int Ed Engl; 2023 Apr; 62(15):e202217993. PubMed ID: 36749546
[TBL] [Abstract][Full Text] [Related]
56. Increased Brain Volume: A Novel Biomarker of Neurodegeneration?
DiFrancesco JC; Stanzani L
Neurology; 2022 Apr; 98(16):649-650. PubMed ID: 35228330
[No Abstract] [Full Text] [Related]
57. Editorial on the Special Issue on SNARE Proteins: A Long Journey of Science in Brain Health and Disease.
Matteoli M; Menna E; Honer WG; Fernández-Chacón R
Neuroscience; 2019 Nov; 420():1-3. PubMed ID: 31634514
[No Abstract] [Full Text] [Related]
58. Frontiers in Neurochemistry.
Ewing A; Choi IS; Green W; Shefi O
Chemphyschem; 2018 May; 19(10):1121-1122. PubMed ID: 29697896
[No Abstract] [Full Text] [Related]
59. Brain Penetrant LRRK2 Inhibitor.
Choi HG; Zhang J; Deng X; Hatcher JM; Patricelli MP; Zhao Z; Alessi DR; Gray NS
ACS Med Chem Lett; 2012 Aug; 3(8):658-662. PubMed ID: 23066449
[TBL] [Abstract][Full Text] [Related]
60. Definition of a molecular pathway mediating α-synuclein neurotoxicity.
Burré J; Sharma M; Südhof TC
J Neurosci; 2015 Apr; 35(13):5221-32. PubMed ID: 25834048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
